EDISON, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Apex Defi Labs Inc., a leader in blockchain-based tokenized securities, proudly announces its strategic partnership with Regiment Securities, LLC (RSLLC ...
Report champions expansion of early access and funding for Canadian Veterans. VANCOUVER, BC, Nov. 17, 2023 /PRNewswire/ - Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming ...
-Patent pending uniquely formulated capsule improves stability and bioavailability for psilocybin and other psychedelics -Supports both APEX-52 take home microdose and APEX-90 in-clinic macrodose ...
Psychiatrist Dr. Mark Johnston as CMO and senior pharmaceutical commercialization expert Greg Rutherford as CCO accelerates APEX's ability to bring new drugs to market. VANCOUVER, BC, Aug. 10, 2023 ...
Authorized to sell psilocybin through Health Canada's Special Access Program. "Receiving this licence is a significant achievement for APEX alongside our tremendous progress actively dosing patients ...
VANCOUVER, BC, June 9, 2023 /PRNewswire/ - Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with clinically proven psilocybin treatments, ...
Israel’s Ministry of Health (MoH) approval to add additional sites to APEX SUMMIT-90 160 patient phase 2b macrodose clinical trial: Tel Aviv University (TAU)’s Institute for Psychedelic Research ...
Apex Test Labs is pleased to announce the acquisition of the operations of the Bureau Veritas Auburn Hills Lab, further enhancing its portfolio of testing services. This strategic move underscores ...
Psychiatrist Dr. Mark Johnston as CMO and senior pharmaceutical commercialization expert Greg Rutherford as CCO accelerates APEX's ability to bring new drugs to market. Dr. Johnston, APEX CMO has been ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback